Solazyme (SZYM) Posts Q2 Loss of $0.43/Share

Solazyme (NASDAQ: SZYM) reported Q2 EPS of ($0.43), $0.07 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $15.9 million versus the consensus estimate of $17.13 million.

For earnings history and earnings-related data on Solazyme (SZYM) click here.

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• Endexx Corporation (EDXC) Reports Q1 Loss of $0.01
• Five Point Holdings, LLC (FPH) Reports Q1 EPS of $0.03